Vaccine for prophylaxis and immunotherapy, Brazil

Clinics in Dermatology

Volumn 14, Issue 5, 1996, Pages 503-512

  Genaro, Odair ^a   De Toledo, Vicente Paulo Coelho Peixoto ^b   Da Costa, Carlos Alberto ^b   Hermeto, Marco Victor ^b   Afonso, Luis Carlos Crocco ^b   Mayrink, Wilson ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEISHMANIA VACCINE;

BRAZIL; CLINICAL TRIAL; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; INFECTION PREVENTION; LEISHMANIA; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0030249180     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00040-5     Document Type: Article

References (44)

1. 1. Pereira GFM, Fonseca HHR. Leishmaniose tegumentar americana: Epidemiologia e controle. Rev Soc Bras Med Trop 1994;27(Suppl. III):45-50.
2. 2. Magalhães PA, Mayrink W, Costa CA da, et al. Calazar na zona do Rio Doce-Minas Gerais. Resultados de medidas profiláticas. Rev Inst Med Trop Sao Paulo 1980;22:197-202.
3. 3. Desjeux P. Information on the epidemiology and control of the leishmaniasis by country and territory. WHO/ Leish/91.30, 1991;47.
4. 4. Lainson R. Our present knowledge of the ecology and control of leishmaniasis in the Amazon region of Brazil. Rev Soc Bras Med Trop 1985;18:47-56.
5. 5. Modabber F. Development of vaccines against leishmaniasis. Scand J Infect Dis 1990;76:72-8.
6. 6. Marinkelle CJ. The control of leishmaniasis. Bull WHO 1980;58:807-18;
7. WHO/TDR News 1991;37:1-2.
8. 7. Mayrink W, Costa CA da, Magalhães PA, et al. A field trial of a vaccine against American dermal leishmaniasis. Trans R Soc Trop Med Hyg 1979;73:385-7.
9. 8. Monjour L, Monjour E, Vouldoukis J, et al. Protective immunity against cutaneous leishmaniasis achieved by partly purified vaccine in a volunteer. Lancet 1986;1:1490.
10. 9. Monjour E, Ogunkolade BW, Vouldoukis J, et al. Immunoprophylaxis against Leishmania infections with a semi-purified antigen. Trans R Soc Trop Med Hyg 1992;80:1013.
11. 10. Salles-Gomes L. Intra-dermoreacção de Montenegro na Leishmaniose e outras pesquizas affins. Bras Med 1939; 49:5-15.
12. 11. Pessoa SB, Pestana BR. Ensaio sobre a vacinação preventiva na leishmaniose tegumentar americana, com germens mortos. Rev Biol Hig 1940;10:112-8.
13. 12. Pessoa SB. Profilaxia da leishmaniose tegumentar no Estado de São Paulo. Folha Med 1941;22:157-61.
14. 13. Pessoa SB. Segunda nota sobre a vacinação preventiva na leishmaniose tegumentar americana com leptomonas mortas. Rev P Med 1941;19:1-9.
15. 14. Mayrink W, Magalhães PA, Dias M, et al. Responses to Montenegro antigen after immunization with killed Leishmania promastigotes. Trans R Soc Trop Hyg 1978;72:676.
16. 15. Barros GC, Sessa PA, Mayrink W, et al. Foco de leishmaniose tegumentar americana no município de Viana -Estado do Espírito Santo. Rev Soc Bras Med Trop 1980; 150.
17. 16. Mayrink W, Williams P, Costa CA da, et al. An experimental vaccine against American dermal leishmaniasis: Experience in the State of Espírito Santo, Brazil. Ann Trop Med Parasitol 1985;79:259-69.
18. 17. Mayrink W, Antunes CMF, Costa CA da, et al. Further trials of a vaccine against American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1986;80:1001.
19. 18. Antunes CMF, Mayrink W, Magalhães PA, et al. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int J Epidemiol 1986;15:572-80.
20. 19. Mayrink W, Schettini APM, Williams P, et al. Histological observations on Montenegro's reaction in man. Rev Inst Med Trop Sao Paulo 1989;31:256-61.
21. 20. Nascimento E, Mayrink W, Costa CA da, et al. Vaccination of humans against cutaneous leishmaniasis: Cellular and humoral immune responses. Infect Immun 1990;58: 2198-203.
22. 21. Mendonça SCF, Restom TG, Conceição-Silva F, et al. Preliminary studies on the immunogenicity of a vaccine against American cutaneous leishmaniasis: proliferative responses of peripheral blood mononuclear cells before and after vaccination. Mem Inst Oswaldo Cruz 1990; 85(Suppl. I):94.
23. 22. Mendonça SCF, Mayrink W, Restom TG, et al. Study on the immunogenicity of a vaccine against cutaneous leishmaniasis in humans. Mem Inst Oswaldo Cruz 1991; 86(Suppl. I):146.
24. 23. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine stimulated human mononuclear phagocytes. Evidence that interferon gamma is the activating lymphokine. J Clin Invest 1983;75:1506-10.
25. 24. Heinzel FP, Sadick JD, Holaday BJ, et al. Reciprocal expression of interferom gamma or interleukin-4 during the resolution or progression of murine leishmaniasis. J Exp Med 1989;169:59-72.
26. 25. Mendonça SCF, De Luca PM, Mayrink W, et al. Characterization of the cell-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis in humans. Mem Inst Oswaldo Cruz 1993;88(Suppl. I):46.
27. 26. Mendonça SCF, De Luca PM, Mayrink W, et al. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Am J Trop Med Hyg 1995;53:195-201.
28. 27. Marzochi KBF, Marzochi MCA, Silva AF, et al. Phase I studies for the Leishvacin (Killed Leishmania vaccine) in Brazil. Workshop on vaccine efficacy trial against leishmaniasis 1995;
29. 28. Hermeto MV, Vieira-Dias D, Toledo VPCP, et al. Immune response in humans vaccinated with differents forms of a killed Leishmania promastigotes vaccine. Mem Inst Oswaldo Cruz 1994;89(Suppl. I):171.
30. 29. Costa CA da, Afonso LCC, Toledo VPCP, et al. Immune responses and protection induced in mice by an industrialized vaccine against American cutaneous leishmaniasis. Parassitologia (Rome) 1992;34:45-51.
31. 30. Santos GC, Toledo VPCP, Mayrink W, et al. Characterization of immune responses induced by different components of a vaccine against American cutaneous leishmaniasis. Mem Inst Oswaldo Cruz 1994;89(Suppl. I):170.
32. 31. Regalado AM, Costa CA da, Mayrink W, et al. Vaccination of C57BL/10 against cutaneous leishmaniasis by semi-purified antigens from Leishmania (L.) amazonensis. Mem Inst Oswaldo Cruz 1992;87(Suppl. I):181.
33. 32. Guimarães TMPD, Toledo VPCP, Costa CA da, et al. Assessment of immunity induced in mice by glycoproteins derived from different strains and species of Leishmania. Mem Inst Oswaldo Cruz 1996;91:63-70.
34. 33. Marsden PD. Pentavalent antimonials: Old drugs for new diseases. Rev Soc Bras Med Trop 1985;18:187-98.
35. 34. Row R. Curative value of Leishmania culture vaccine in Oriental sore. Br Med J 1912;9:540-1.
36. 35. Di Cristina, Caronia G. Primi tentativi di vaccinazione graduale nell anemia da Leishmania con culture morte. Trop Dis Bull 1912;1:332.
37. 36. Dubovsky P. Vaccinotherapy of cutaneous leishmaniasis. Trop Dis Bull 1943;40:297.
38. 37. Michalick MSM, Mayrink W, Magalhǎes PA, et al. Imunoterapia na leishmaniose tegumentar americana. X Congresso Sociedade Brasileiro de Parasitologia 1987;119.
39. 38. Mayrink W, Michalick MSM, Melo MN, et al. Tratamento da Leishmaniose tegumentar americana utilizando vacina. An Bras Derm 1991;66:55-9.
40. 39. Mayrink W, Magalhães PA, Michalick MSM, et al. Immunotherapy as a treatment of American cutaneous leishmaniasis: Preliminary studies in Brazil. Parassitologia (Rome) 1992;34:159-65.
41. 40. Silveira FT, Mayrink W. Leishmaniose cutaneo difusa no Estado do Pará, Brasil: Registro do primeiro caso de cura da doen ça, após associação de quimioterapia com imunoterapia. Rev Soc Bras Med Trop 1993;229.
42. 41. Hermeto MV, Castanol MCMN, Cunha RC, et al. Antimony-resistant American Cutaneous Leishmaniasis treated with immunotherapy. Mem Inst Oswaldo Cruz 1992;87(Suppl. I):187.
43. 42. Da-Cruz AM, Mayrink W, Filgueiras D, et al: Imunoquimioterapia em um paciente com leishmaniose mucocutânea e Sida: estudos imunológicos. Rev Soc Bras Med Trop 1994;27(Suppl. 1):388.
44. 43. Cunha RMC, Hallack KA, Mayrink W, et al. Leishmaniose disseminada em paciente infectado pelo virus HIV. Evolução clínico-morfológica atípica. Rev Soc Bras Med Trop 1994;27(Suppl. I):389.